title: Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).
abstract: This report updates the 2003 recommendations by the Advisory Committee on Immunization Practices (ACIP) on the use of influenza vaccine and antiviral agents (CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices [ACIP]. MMWR 2003;52[No. RR-8]:1-34). The 2004 recommendations include new or updated information regarding 1) influenza vaccine for children aged 6-23 months; 2) vaccination of health-care workers with live, attenuated influenza vaccine (LAIV); 3) personnel who may administer LAIV; 4) the 2004-05 trivalent inactivated vaccine virus strains: A/Fujian/411/2002 (H3N2)-like, A/New Caledonia/20/99 (H1N1)-like, and B/Shanghai/361/2002-like antigens (for the A/Fujian/411/2002 (H3N2)-like antigen, manufacturers may use the antigenically equivalent A/Wyoming/3/2003 [H3N2] virus, and for the B/Shanghai/361/2002-like antigen, manufacturers may use the antigenically equivalent B/Jilin/20/2003 virus or B/Jiangsu/10/2003 virus); and 5) the assessment of vaccine supply and timing of influenza vaccination. A link to this report and other information regarding influenza can be accessed at http://www.cdc.gov/flu.
authors.affiliation: Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, CDC, USA.
authors.forename: Scott A
authors.initials: SA
authors.lastname: Harper
authors.forename: Keiji
authors.initials: K
authors.lastname: Fukuda
authors.forename: Timothy M
authors.initials: TM
authors.lastname: Uyeki
authors.forename: Nancy J
authors.initials: NJ
authors.lastname: Cox
authors.forename: Carolyn B
authors.initials: CB
authors.lastname: Bridges
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000998:Antiviral Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D017281:Cost of Illness; D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D007223:Infant; D007252:Influenza Vaccines / Q000008:administration & dosage* / Q000191:economics; D007251:Influenza, Human / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control*; D008297:Male; D008875:Middle Aged; D011247:Pregnancy; D011310:Preservatives, Pharmaceutical; D013849:Thimerosal; D014481:United States / Q000453:epidemiology; D014611:Vaccination / Q000592:standards / Q000706:statistics & numerical data; D014613:Vaccines, Attenuated / Q000008:administration & dosage; D015164:Vaccines, Inactivated / Q000008:administration & dosage
chemical_list: D000998:Antiviral Agents; D007252:Influenza Vaccines; D011310:Preservatives, Pharmaceutical; D014613:Vaccines, Attenuated; D015164:Vaccines, Inactivated; D013849:Thimerosal